Bill > HB1973

Introduced Session

Tetrahydrocannabinol; industrial hemp; regulated hemp Tetrahydrocannabinol; industrial hemp; regulated hemp products. Establishes provisions for the registration of a retail facility for regulated hemp products, as defined in the bill, establishes product packaging, labeling, and testing requirements for such products, and creates a civil penalty of up to $1,000 for certain violations relating to such products. The bill requires any person who manufactures an industrial hemp extract, as defined in the bill, or food containing an industrial hemp extract to obtain a permit from the Commissioner of Agriculture and Consumer Services and creates a Class 1 misdemeanor and a civil penalty of up to $10,000 for certain violations. The bill clarifies that any substances containing a concentration of total tetrahydrocannabinol, as defined in the bill, of more than 0.3 percent, including a hemp product or industrial hemp extract, are included in the definition of marijuana and also clarifies that the definition of marijuana does not include any substance containing tetrahydrocannabinol that has been placed by the Board of Pharmacy into one of the schedules set forth in the Drug Control Act. The bill increases the civil penalty for certain actions relating to sales of cigarettes and hemp products from $50 to $500. The bill also removes tetrahydrocannabinol from the Schedule I list of controlled substances and permits the Board of Pharmacy to schedule, deschedule, or reschedule a tetrahydrocannabinol isomer, except delta-9-tetrahydrocannabinol, or salts of such isomer in accordance with the provisions of the bill.

AI Summary

Committee Categories

James Leftwich (R)*,  G. John Avoli (R),  Rob Bloxom (R),  Aijalon Cordoza (R),  Tara Durant (R),  C. Matthew Fariss (R),  Anne Ferrell Tata (R),  Chris Head (R),  M. Keith Hodges (R),  Ellen McLaughlin (R),  Robert Orrock (R),  Chris Runion (R),  Wendell Walker (R),  William Wiley (R), 

Failed to pass in House (on 02/25/2023)

Official Document